These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30802757)

  • 1. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.
    Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
    J Crit Care; 2019 Jun; 51():117-121. PubMed ID: 30802757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
    Lorente L; Martín MM; López P; Ramos L; Blanquer J; Cáceres JJ; Solé-Violán J; Solera J; Cabrera J; Argueso M; Ortiz R; Mora ML; Lubillo S; Jiménez A; Borreguero-León JM; González A; Orbe J; Rodríguez JA; Páramo JA
    PLoS One; 2014; 9(4):e94370. PubMed ID: 24728097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.
    Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2019 Jul; 19(1):167. PubMed ID: 31319804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.
    Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A
    World Neurosurg; 2020 Feb; 134():e476-e480. PubMed ID: 31669537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
    Lorente L; Martín MM; Labarta L; Díaz C; Solé-Violán J; Blanquer J; Orbe J; Rodríguez JA; Jiménez A; Borreguero-León JM; Belmonte F; Medina JC; Llimiñana MC; Ferrer-Agüero JM; Ferreres J; Mora ML; Lubillo S; Sánchez M; Barrios Y; Sierra A; Páramo JA
    Crit Care; 2009; 13(5):R158. PubMed ID: 19799791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
    Lorente L; Martín MM; Solé-Violán J; Blanquer J; Labarta L; Díaz C; Borreguero-León JM; Orbe J; Rodríguez JA; Jiménez A; Páramo JA
    PLoS One; 2014; 9(4):e94318. PubMed ID: 24727739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients.
    Lorente L; Martín MM; Abreu-González P; Ramos L; Cáceres JJ; Argueso M; Solé-Violán J; Jiménez A; García-Marín V
    BMC Res Notes; 2019 Dec; 12(1):789. PubMed ID: 31796118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma matrix metalloproteinase-9 levels predict intensive care unit mortality early after severe traumatic brain injury.
    Simon D; Evaldt J; Nabinger DD; Fontana MF; Klein MG; do Amaral Gomes J; Regner A
    Brain Inj; 2017; 31(3):390-395. PubMed ID: 28156136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.
    Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; García-Marín V
    World Neurosurg; 2019 Jun; 126():e1537-e1541. PubMed ID: 30926559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
    Wang M; Zhang Q; Zhao X; Dong G; Li C
    Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
    Alqahtani MF; Smith CM; Weiss SL; Dawson S; Ralay Ranaivo H; Wainwright MS
    PLoS One; 2016; 11(4):e0153645. PubMed ID: 27089280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Matrix Metalloproteinases and Their Inhibitors for Mortality in Septic Patients: A Cohort Study.
    Serrano-Gomez S; Burgos-Angulo G; Niño-Vargas DC; Niño ME; Cárdenas ME; Chacón-Valenzuela E; McCosham DM; Peinado-Acevedo JS; Lopez MM; Cunha F; Pazin-Filho A; Ilarraza R; Schulz R; Torres-Dueñas D
    J Intensive Care Med; 2020 Jan; 35(1):95-103. PubMed ID: 28931365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    World Neurosurg; 2019 Dec; 132():e613-e617. PubMed ID: 31442647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
    Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
    Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.
    Hästbacka J; Fredén F; Hult M; Bergquist M; Wilkman E; Vuola J; Sorsa T; Tervahartiala T; Huss F
    PLoS One; 2015; 10(5):e0125918. PubMed ID: 25945788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 after burn injury.
    Nagy B; Szélig L; Rendeki S; Loibl C; Rézmán B; Lantos J; Bogár L; Csontos C
    J Crit Care; 2015 Feb; 30(1):162-6. PubMed ID: 25155253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients.
    Mroczko B; Groblewska M; Łukaszewicz-Zajac M; Bandurski R; Kedra B; Szmitkowski M
    Clin Chem Lab Med; 2009; 47(9):1133-9. PubMed ID: 19728856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study.
    Nukarinen E; Lindström O; Kuuliala K; Kylänpää L; Pettilä V; Puolakkainen P; Kuuliala A; Hämäläinen M; Moilanen E; Repo H; Hästbacka J
    PLoS One; 2016; 11(8):e0161480. PubMed ID: 27561093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury.
    Lorente L; Martín MM; Almeida T; Abreu-González P; Ramos L; Argueso M; Riaño-Ruiz M; Solé-Violán J; Jiménez A
    BMC Neurol; 2015 Jul; 15():115. PubMed ID: 26205136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.